Your browser doesn't support javascript.
loading
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma.
Zhao, Wan-Hong; Liu, Jie; Wang, Bai-Yan; Chen, Yin-Xia; Cao, Xing-Mei; Yang, Yun; Zhang, Yi-Lin; Wang, Fang-Xia; Zhang, Peng-Yu; Lei, Bo; Gu, Liu-Fang; Wang, Jian-Li; Yang, Nan; Zhang, Ru; Zhang, Hui; Shen, Ying; Bai, Ju; Xu, Yan; Wang, Xu-Geng; Zhang, Rui-Li; Wei, Li-Li; Li, Zong-Fang; Li, Zhen-Zhen; Geng, Yan; He, Qian; Zhuang, Qiu-Chuan; Fan, Xiao-Hu; He, Ai-Li; Zhang, Wang-Gang.
Afiliación
  • Zhao WH; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Liu J; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Wang BY; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Chen YX; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Cao XM; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Yang Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Zhang YL; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Wang FX; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Zhang PY; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Lei B; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Gu LF; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Wang JL; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Yang N; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Zhang R; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Zhang H; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Shen Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Bai J; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Xu Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Wang XG; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Zhang RL; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Wei LL; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Li ZF; National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, ShaanXi, China.
  • Li ZZ; National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, ShaanXi, China.
  • Geng Y; Department of Clinical Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, ShaanXi, China.
  • He Q; Department of Clinical Laboratory, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, ShaanXi, China.
  • Zhuang QC; Nanjing Legend Biotech Inc., Nanjing, 210000, Jiangsu, China.
  • Fan XH; Nanjing Legend Biotech Inc., Nanjing, 210000, Jiangsu, China.
  • He AL; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West 5th Road, Xi'an, 710004, ShaanXi, China.
  • Zhang WG; National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, ShaanXi, China.
J Hematol Oncol ; 11(1): 141, 2018 12 20.
Article en En | MEDLINE | ID: mdl-30572922
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígeno de Maduración de Linfocitos B / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antígeno de Maduración de Linfocitos B / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido